15
2022Cherry
AGENCY STATEMENT
We are a full-service award-winning global healthcare communications agency that grows brands and careers.

- Agency description
Hello, we are Cherry
We do everything other full-service healthcare creative agencies do.
So what makes us different?
We take good care of our clients - supporting their growth, and the growth of their brands, as they have supported ours. And as our clients' careers progress, they keep coming back.
Visit us at www.cherrythinking.com to learn why.
- Contact details
- Riverside House, Levels 5 & 6 2A Southwark Bridge London, SE1 9HA UK
- +44 207 940 7310
- samantha.walsh@cherrythinking.com
- https://www.cherrythinking.com
- Key contact
- Samantha Walsh
- Deputy Managing Director
- samantha.walsh@cherrythinking.com
- +44 7951 329 649
- 2022 Agency Data
-
2021 awardsTotal staff100-149 staffBillings from UK creative healthcare workHealthcare staff100-149 staffTotal agency billingsAgency ageBetween 15 and 20 yearsSocial media footprintStatusNETWORKEDApproximate percentage of advertising, branding, creative or design work in the UK healthcare market20-29%
- This information was supplied or confirmed by Cherry. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- Awards
- 2021 PMSociety Awards:
Finalist, Advertisement (primary or secondary care) and Disease Awareness (HCP), Little MOAnsters
Silver, Interactive Communications for HCP, The Balancing Act for Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma - This may contain additional awards supplied by Cherry that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
This listing was produced in good faith using data supplied by the agencies and data in the public domain. Some data may not have been independently verified by PMLiVE. This is not an exhaustive list of all agencies working in the UK. Find out how the list was created and the methodology used here.
COVID-19 Updates and Daily News
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
Quick links
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Genmab hires first chief operating officer
- A relentless commitment to neuroscience